Kazia KZIA 深 沪
已收盘 04-02 16:00:00 美东时间
7.34
+0.160
+2.23%
华盛通- 最 高7.45
- 今 开7.05
- 成交量 2.85万股
- 最 低 7.04
- 昨 收 7.18
- 总市值 8387.34万
- 52周最高 17.40
- 市盈率 静 --
- 换手率 0.25%
- 52周最低 2.90
- 委 比 -90.48%
- 总股本 1142.69万
- 历史最高 744.50
- 量 比 0.15
- 振 幅 5.71%
- 历史最低 3.005
- 每 手 1
- 风险率 2.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 希捷科技、德州仪器、HCA控股、通用汽车、波音、UPS等或多家机构上调目标价；布朗保险、康沃系统、Qorvo、联合健康等遭多家机构下调目标价
今日重点评级关注：Piper Sandler：维持Praxis Precision Medicine"超配"评级，目标价从450美元升至1200美元；Tigress Financial：维持Main International ETF"买入"评级，目标价从52美元升至66美元
01-29 11:06
Kazia Therapeutics Announces Three Patients With Metastatic Triple-Negative Breast Cancer With Paxalisib-Based Regimens Have Demonstrated Meaningful Clinical Responses In Phase 1b Trial Of Paxalisib In Combination With Pembrolizumab And Chemotherapy
Kazia Therapeutics (NASDAQ: KZIA), today provided a clinical update from its ongoing Phase 1b study evaluating paxalisib in combination with pembrolizumab and chemotherapy in patients with late-stage (Stage IV),
01-27 21:11
How $594B in Precision Tech is Cracking the Metastatic Cancer Code
Issued on behalf of Oncolytics Biotech Inc. USANewsGroup.com News Commentary VANCOUVER, BC, Jan. 7, 2026 /PRNewswire/ -- The global cancer drugs market is surging toward $594.3 billion by 2...
01-07 23:32
Is the Market Bullish or Bearish on Kazia Therapeutics Ltd?
Kazia Therapeutics Ltd's (NYSE:KZIA) short interest as a percent of float has f...
2025-12-27 01:00
Kazia Therapeutics Regains Full Nasdaq Listing Compliance
Restoration of Nasdaq compliance follows $50 million institutional financing and reinforces balance-sheet strength SYDNEY, Dec. 22, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" o...
2025-12-22 21:00
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
2025-12-15 15:30
Kazia Therapeutics Says First Patient From TNBC Trial Demonstrated 76% Tumor Volume Shrinkage With Corresponding Reductions In CTC And Clusters
First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clustersReinvigoration of immune system + turning cold tumors hotPreliminary
2025-12-10 21:07
What's Going On With Cancer Firm Kazia Therapeutics
Kazia announced a private placement of $50 million in equity securities. Proceeds will fund clinical development and extend cash runway.
2025-12-03 01:21
Kazia Therapeutics Announces ~$50M PIPE, Selling Ordinary Shares And Pre-Funded Warrants At A Price Equivalent To $5.00 Per ADS, Each ADS Representing 500 Ordinary Shares, With Expected Net Proceeds Of ~$46.5M
Kazia Therapeutics Limited (NASDAQ:KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional and accredited
2025-12-02 22:06
BUZZ-U.S. STOCKS ON THE MOVE-Constellation Energy, Williams-Sonoma
Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes inched ...
2025-11-19 23:59
